Leaders at the FDA, HHS and elsewhere are putting guardrails around COVID-19 boosters, which could mean delayed shots or ...

Amid a trade war that could strain imports of lifesaving pharmaceuticals, President Donald Trump wants to ease regulations ...

Following immunotherapy treatments in the last decade, new therapeutic strategies for cancer are beginning to emerge.

Seventy-five years of preparation for an outbreak like that of COVID-19—and yet, the Centers for Disease Control and ...

Donald Trump has recently made a range of nominations/appointments in the US health sector. They will influence conventional and so-called alternative medicine (SCAM) in the US and beyond. It ...

PHILADELPHIA -- The next big world war won't be a nuclear war, or a chemical war -- it will be a war with bioweapons, said ...

Vaccine maker Novavax is seeking to convert the 2022 emergency authorization of its Covid-19 vaccine into full approval. Yet ...

Experts have cautioned against adopting the technology too quickly for clinical purposes. The first meeting of FDA’s Digital ...

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...

Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.

In a May 8 letter to HHS Secretary Robert F. Kennedy Jr. provided exclusively to KFF Health News, Wyden, the top Democrat on ...

FDA commissioner Marty Makary told FDA staff in an email that Prasad, “brings a great set of skills, energy, and competence ...